Floatz logo

gp96

Glioma of Brain

Cure&Sure Biotech Co., LTDPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Glioma of Brain cohort.

Asset / SponsorPhaseRating
FDOPA
University of Alberta
Phase 3B
Ganciclovir
Huazhong University of Science and Technology
Phase 2B
Everolimus
St. Joseph's Hospital and Medical Center, Phoenix
Phase 1B
Adv-Tk
Huazhong University of Science and Technology
Phase 2B
Ribociclib
St. Joseph's Hospital and Medical Center, Phoenix
Phase 1B

View all 23 →

Same molecule, other indications

gp96 is also rated in:

pancreatic adenocarcinomaDormant
CC
Indicative ·
43 / 100
View asset →
gliomaDormant
CC
Indicative ·
42 / 100
View asset →
liver cancerDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →